Latest News
iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day
BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...
OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
TOKYO, June 5, 2022 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has closed Series B2 financing from Asahi Kasei Medical Co., Ltd. OriCiro has advanced its busine...
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...
Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform
SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...
LILYSILK Honors World Environment Day with Sustainable Living Initiatives
LOS ANGELES, June 5, 2022 /PRNewswire/ -- In conjunction with this year's
World Environment Day
Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements
BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...
Dogness (International) Corporation Closes $12 Million Offering
DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...
Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge
SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...
Gracell Biotechnologies Schedules Clinical Update Call After EHA2022
SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...
ASIP Tech selected by Wizz Air for free inflight connectivity
NEW YORK, June 3, 2022 /PRNewswire/ -- AS-IP Tech (USOTC: IPTK) announced today it has signed an agreement with Wizz Air (LSE: WIZZ) to provide connectivity on its fleet of A320 and A321 UK based aircraft. In a world first, Wizz Air will integrate AS-IP Tech's fflya Bluetooth platform into its m...
JX Luxventure receives Nomination for the "Best Software Solution Provider" Award
HAIKOU, China, June 3, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a company delivering comprehensive products solutions to global elite families serviced by our business customers with business segments covering menswear, cross-border merchandise and tourism, announ...
Sylvox Outdoor TV Big Savings Event in Walmart+ Weekend
LOS ANGELES, June 3, 2022 /PRNewswire/ -- Sylvox
ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
SAN FRANCISCO, June 3, 2022 /PRNewswire/ -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus ...
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE
SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...
New Articles for May Issue of "KIZUNA," Official E-magazine of Japanese Government
TOKYO, June 3, 2022 /PRNewswire/ -- The Japanese government publishes new
articles every month in an official e-magazine, "KIZUNA." Six new articles,
published in May, are outlined below.
Logo:
https://kyodonewsprwire.jp/prwfile/release/M107127/202206022026/_prw_PI2fl_W13w7HMJ.jpg
CANACCORD GENUITY GROUP INC. REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS
Excluding significant items, quarterly earnings per common share of $0.52 (1) Excluding significant items, record full fiscal year earnings per common share of$2.51 (1) Fiscal 2022 common share year dividend payout increased 28% year-over-year TORONTO, June 3, 2022 /PRNewswire/ -- Canaccord Genuit...
Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform Announced - World Premiere
SHANGHAI, June 2, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals officially
launched STAL (Super-Trillion Antibody Libraries) onJune 3, 2022, which is a
super-trillion innovative antibody drug discovery platform of Sanyou's own
intellectual property.
Jelenew and Stephane Rolland, tailor-made cycling pants-haute couture dress for star Kat Graham to attend the red carpet of the 75th Cannes Film Festival
Kat Graham, named the best-dressed stars at the 2022 Cannes Film Festival by
Harper's Bazaar.
WILMINGTON, Del. , June 2, 2022 /PRNewswire/ -- On May 28, actress Kat Graham
made a stunning appearance on the red carpet of the closing ceremony of the
2022 Cannes Film Festival in Jelenew
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55